| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.025 | 1 |